RecallRadar
High RiskReported March 11, 2026

MR. 7 SUPER 700000 capsules, 1 capsule blister card

Recalled by StuffbyNainax

Drug recall

StuffbyNainax

Class I — most serious

There is a reasonable chance that using this product could cause serious health problems or death.

See all recalls involving an undeclared allergen

StuffbyNainax has recalled MR. 7 SUPER 700000 capsules, 1 capsule blister card, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on March 11, 2026 and was initiated on December 15, 2025. It is classified as a Class I recall, which means there is a reasonable chance that using this product could cause serious health problems or death.

Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.

What was recalled?

This recall covers MR. 7 SUPER 700000 capsules, 1 capsule blister card, with approximately 4 affected. The company behind the recall is StuffbyNainax, based in Huntsville, TX. The FDA describes the product as: “MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7”

Why was MR. 7 SUPER 700000 capsules, 1 capsule blister card recalled?

According to the FDA, the stated reason for the recall is: “Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil.” In plain terms, this recall relates to an undeclared ingredient or allergen.

An undeclared ingredient means a food contains something — often a major allergen such as milk, eggs, soy, wheat, peanuts, or tree nuts — that is not listed on the label. For most people this is not dangerous, but for someone with a food allergy or sensitivity it can trigger a serious reaction. Accurate labeling is required so that people can avoid ingredients they need to stay away from.

What should you do?

If you think you may have bought MR. 7 SUPER 700000 capsules, 1 capsule blister card, compare it against the product description and identifying codes (All codes; Exp 12/31/2029) before using it. This recall is currently listed as ongoing.

The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact StuffbyNainax or your local health authority.

About this recall

This recall was distributed in TX. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.

Full recall details

Status
Ongoing
Date reported
March 11, 2026
Recall started
December 15, 2025
Distributed in
TX
What was recalled
MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7
Why it was recalled (as stated by the FDA)
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
How to identify the affected product
All codes; Exp 12/31/2029
Amount recalled
4

What you can do

Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.

Quick answers

Why was MR. 7 SUPER 700000 capsules, 1 capsule blister card recalled?+

According to the FDA: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafi…

How serious is this recall?+

Class I — most serious. There is a reasonable chance that using this product could cause serious health problems or death.

What should I do if I have MR. 7 SUPER 700000 capsules, 1 capsule blister card?+

Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.

Share this recall:PostShareEmail
View the official FDA record

Opens the U.S. Food and Drug Administration (FDA) data for this recall.

Recall number: D-0397-2026. Information last synced from the FDA on July 6, 2026.